In the first eye, systemic corticosteroid and intravitreal anti-vascular endothelial growth factor achieved good control of the disc edema and cystoid macular edema, while intravitreal dexamethasone implant in the fellow eye achieved similar response. This evidence concerns the gene VEGFA and Cystoid macular dystrophy.